The size of the Asia Pacific IV Equipment Market was valued at USD 2.13 billion in 2020 and estimated to grow at a CAGR of 6.9%, to reach USD 2.98 billion by 2025.
Intravenous therapy is the fusion of liquid components directly into a vein. Intravenous (IV) means inside vein. Intravenous infusions are commonly referred to as drips. The intravenous route is the most rapid way to deliver fluids and medications all over the body.
An upsurge in human services spending and advancement of medicinal services foundation Diabetes, gastrointestinal infections, ascend in malignancy, neurological conditions and lack of healthy sustenance are main scale drivers affecting business sector improvement, particularly in rising nations. Older people and expanded access to palliative care keeps on driving interest for IV hardware for medication and supplement implantation of sicknesses. The Asia Pacific IV Equipment market is emerging at a remarkably rapid speed.
Asia Pacific IV Equipment Market has been segmented and sub-segmented into the following categories:
Regional Analysis
Based on the region, China and India are likely to increase the market because of the vast population. Also, Asia Pacific is the fastest-growing region in the global market due to the rapid growth and expansion of the pharmaceutical and medical device industries.
Chinese IV Equipment Market has accounted for leading shares in the Asia Pacific market in 2019. China is the centre of CVD and lethal diseases and has excellent healthcare infrastructure and manufacturers of an intravenous catheter, intravenous infusion pumps and syringes.
Indian IV Equipment Market is estimated to witness a healthy growth rate during the forecast period. High-level awareness about health, technology evolution in Intravenous equipment and adoption of minimally invasive surgeries are majorly driving the market growth. Rising incidence of the diabetic epidemic in this country is estimated to spur the growth. According to the National Diabetes and Diabetic Retinopathy Survey, the prevalence of diabetes in India is 11.8% in the last four years.
Top Companies leading the Asia Pacific IV Equipment Market are ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), Moog, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 IV Catheters
5.1.2 Administration Sets
5.1.3 Infusion Sets
5.1.4 Securement Devices
5.1.5 Stopcocks and Check Valves
5.1.6 Drip Chambers
5.1.7 Needleless Connectors
5.1.8 Other IV Equipment
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2 End User
5.2.1 Hospitals and Clinics
5.2.2 Home Care
5.2.3 Ambulatory Care Centers
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson and Company (U.S.)
8.3 B. Braun Melsungen AG (Germany)
8.4 Baxter International Inc. (U.S.)
8.5 Fresenius SE & Co. KGaA (Germany)
8.6 ICU Medical, Inc. (U.S.)
8.7 Smiths Medical (U.K.)
8.8 Moog, Inc. (U.S.)
8.9 Terumo Corporation (Japan.)
8.10 C. R. Bard, Inc. (U.S.)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
